Trials / Completed
CompletedNCT01421381
RHODOS Follow-up Single-visit Study
A Single Visit, Observational, Follow-up Study of Patients With Leber's Hereditary Optic Neuropathy Following Participation in SNT-II-003 Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Santhera Pharmaceuticals · Industry
- Sex
- All
- Age
- 15 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the current visual acuity of SNT-II-003 participants and compare this with the last visit from the SNT-II-003 study.
Conditions
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2011-11-01
- Completion
- 2011-12-01
- First posted
- 2011-08-22
- Last updated
- 2013-05-27
Locations
3 sites across 3 countries: Canada, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01421381. Inclusion in this directory is not an endorsement.